Nigeria responds to a meningitis outbreak

In a dated interview, Anastasia Yirenkyi described integration of traditional and complementary care.

Yirenkyi described pilot services that began in 2017, distinguishing their start from the interview date.

The interview discussed Ghana’s centre for plant-based medicine and links with universities.

Yirenkyi described professional training, registration and quality oversight.

A news release described a March vaccination campaign using Men5CV against five meningococcal groups.

Men5CV can protect against several causes of meningococcal meningitis, depending on the group.

The entry is dated to WHO’s 12 April report; the initial rollout took place in March.

WHO prequalified the TAK-003 dengue vaccine on 10 May, later reporting the decision.

The prequalification supports procurement for countries with appropriate dengue vaccine policies.

The vaccine is recommended for children in particular high-transmission settings, not for every population.